Brief: QuidelOrtho Receives FDA 510(K) Clearance For Its QuickVue Covid-19 Test
02/04/2024 16:26
April 2 (Reuters) - QuidelOrtho Corp QDEL.O :
* QUIDELORTHO RECEIVES FDA 510(K) CLEARANCE FOR ITS
QUICKVUE®
COVID-19 TEST
* QUIDELORTHO CORP - ANTICIPATES NEW MULTIPLEX ASSAY TO BE
COMMERCIALLY AVAILABLE DURING 2024/2025 RESPIRATORY SEASON
Source text for Eikon: ID:nBw3qG5Sfa
Further company coverage: QDEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quidelortho
See all newsBrief: Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026
QuidelOrtho Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: QuidelOrtho Q2 EPS USD -1.36
Media: QuidelOrtho looks to sell testing unit as PE circles healthcare companies - FT
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras